Cellular Proliferation by Multiplex Immunohistochemistry Identifies High-Risk Multiple Myeloma in Newly Diagnosed, Treatment-Naive Patients Academic Article uri icon

Overview

MeSH Major

  • Adenosine Kinase
  • Antineoplastic Agents
  • Lymphoma, Primary Effusion
  • Purine Nucleosides

abstract

  • PCPI is a practical method that predicts OS in newly diagnosed myeloma and facilitates broader use of MM cell proliferation for risk stratification.

publication date

  • January 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.clml.2017.09.010

PubMed ID

  • 29051077